|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online January 12, 2006
doi: 10.1242/10.1242/jcs.02733
Research Article |
Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110, USA
e-mail: beatty{at}borcim.wustl.edu
Accepted 5 October 2005
Chlamydiae are obligate intracellular bacterial pathogens that replicate solely within the confines of a membrane-bound vacuole termed an inclusion. Within this protected organelle, chlamydiae acquire host-cell-derived biosynthetic precursors necessary for intracellular subsistence, yet the mechanisms and pathways responsible for this acquisition remain elusive. The present study identifies an interaction between the chlamydial inclusion and multivesicular bodies, complex organelles pivotal in protein and lipid transport that are positioned along the endosome-lysosome pathway, and intersect the exocytic pathway in various cell types. Resident protein and lipid constituents of multivesicular bodies colocalized with intracellular chlamydiae, with direct delivery of the resident protein CD63 to the chlamydial inclusion. Interruption of trafficking from multivesicular bodies by pharmacological inhibitors and exogenous antibodies subsequently disrupted sphingolipid delivery to the maturing chlamydial inclusion and intracellular bacterial growth. This study identifies a trafficking pathway from CD63-positive multivesicular bodies to the bacterial inclusion, a novel interaction that provides essential lipids necessary for maintenance of a productive intracellular infection.
Key words: Chlamydia trachomatis, Multivesicular bodies, CD63, Trafficking
This article has been cited by other articles:
![]() |
J. L. Cocchiaro, Y. Kumar, E. R. Fischer, T. Hackstadt, and R. H. Valdivia From the Cover: Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole PNAS, July 8, 2008; 105(27): 9379 - 9384. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Beatty Late Endocytic Multivesicular Bodies Intersect the Chlamydial Inclusion in the Absence of CD63 Infect. Immun., July 1, 2008; 76(7): 2872 - 2881. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Huang, S. Gilfillan, S. Kim, B. Thompson, X. Wang, A. J. Sant, D. H. Fremont, O. Lantz, and T. H. Hansen MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells J. Exp. Med., May 12, 2008; 205(5): 1201 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Shivshankar, L. Lei, J. Wang, and G. Zhong Rottlerin Inhibits Chlamydial Intracellular Growth and Blocks Chlamydial Acquisition of Sphingolipids from Host Cells Appl. Envir. Microbiol., February 15, 2008; 74(4): 1243 - 1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Brumell and M. A. Scidmore Manipulation of Rab GTPase Function by Intracellular Bacterial Pathogens Microbiol. Mol. Biol. Rev., December 1, 2007; 71(4): 636 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cortes, K. A. Rzomp, A. Tvinnereim, M. A. Scidmore, and B. Wizel Chlamydia pneumoniae Inclusion Membrane Protein Cpn0585 Interacts with Multiple Rab GTPases Infect. Immun., December 1, 2007; 75(12): 5586 - 5596. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Moorhead, K. A. Rzomp, and M. A. Scidmore The Rab6 Effector Bicaudal D1 Associates with Chlamydia trachomatis Inclusions in a Biovar-Specific Manner Infect. Immun., February 1, 2007; 75(2): 781 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Muschiol, L. Bailey, A. Gylfe, C. Sundin, K. Hultenby, S. Bergstrom, M. Elofsson, H. Wolf-Watz, S. Normark, and B. Henriques-Normark A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis PNAS, September 26, 2006; 103(39): 14566 - 14571. [Abstract] [Full Text] [PDF] |
||||